跳至主要内容
临床试验/NL-OMON34644
NL-OMON34644已完成不适用

A Dose-Response Study of Human Unacylated Ghrelin on Glycemia during Oral Glucose Tolerance Test in Patients with Type 2 Diabetes Mellitus - UAG oGTT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Female or Male subject of 18 years of age or older;
  • Documented diagnosis of type 2 diabetes as defined by American Diabetes Association;
  • Diagnosis of type 2 diabetes for at least 3 months prior to screening;
  • Metformin monotherapy for at least 3 months prior to screening is allowed
  • Screening HbA1c between 6.5% and 8.5%;
  • Body Mass Index between 25 and 35 kg/m2;

排除标准

  • History of or presence of active concomitant conditions or disease that would interfere with the protocol conduct and study assessments, as judged by the investigator;
  • History or presence of long-term type 2 diabetes complications;
  • Clinically significant abnormalities in laboratory evaluation at screening, as judged by the investigator;
  • Use of systemic corticosteroids within 60 days prior to screening;
  • If female, pregnancy or breast feeding;
  • Drug or alcohol dependence or abuse;
  • Participation in a trial of an experimental drug or device within 60 days prior to screening

研究者

相似试验